Clinical Trial Update: Phase II Study of Docetaxel +/- Nintedanib in Breast Cancer [Phase 2]

View source ↗

Summary

Phase II clinical trial investigating docetaxel with or without nintedanib for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Docetaxel (Taxotere) (docetaxel)
• Nintedanib (nintedanib)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED